Description
Clensia is a medication currently being studied in Phase 4 clinical trials for colorectal cancer screening. It is an evacuating solution, meaning it is designed to help clear the bowel before a colonoscopy. The goal of the trial is to see how well Clensia works in preparing patients for colonoscopy screening to detect colorectal cancer and how well patients tolerate it. It contains simethicone, an ingredient often used to reduce gas and bloating.
Mechanism of Action
Clensia is an evacuating solution. Its mechanism involves helping to clear the colon of stool, which is necessary for a clear view during a colonoscopy. The specific ingredients and their precise actions are being evaluated in clinical trials, but the general purpose is bowel preparation.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.